REUMATOLOGÍA

2001

Artículos

Galindo M, Santiago B, Alcamí J, Rivero M, Martín Serrano J, Pablos JL. Hypoxia induces expression of the chemokines monocyte chemoattractant protein-1 (MCP-1) and IL-8 in human dermal fibroblasts. Clin Exp Immunol. 2001;123(1):36-41 [doi

Galindo M, Santiago B, Rivero M, Rullas J, Alcamí J, Pablos JL. Chemokine expression by systemic sclerosis fibroblasts: abnormal regulation of monocyte chemoattractant protein 1 expression. Arthritis Rheum. 2001;44(6):1382-6 [doi

Martínez Salio A, B. Joven B, L. Galán L, Vicente Fatela L. Varón con dolor y pérdida de fuerza en miembros inferiores. Rev Soc Esp Dolor. 2001;8:63-6

Santiago B, Galindo M, Rivero M, Pablos JL. Decreased susceptibility to Fas-induced apoptosis of systemic sclerosis dermal fibroblasts. Arthritis Rheum. 2001;44(7):1667-76

.

2002

Artículos

Almodóvar R, Blanch Rubió J. Actualización en el tratamiento de la enfermedad ósea de Paget. Revisión sistemática.  Semin Fund Esp Reumatol. 2002;3(5):229-36

Carreira PE. Tratamiento “de fondo” de la esclerosis sistémica: Pasado, presente y futuro. Semin Fund Esp Reumatol. 2002;3(1):20-8

González Crespo MR. Diagnóstico de las miopatías. Rev Clin Esp. 2002;202(2):91-3

González Crespo MR. Miopatías inflamatorias idiopáticas. Rev Clin Esp. 2002;202(9):500-8

Pablos JL, Galindo M, Santiago B. Bases inflamatorias de la artrosis. Semin Fund Esp Reumatol. 2002;3(6):261-7

Rivero M, Santiago B, Galindo M, Brehmer MT, Pablos JL. Cyclooxygenase-2 inhibition lacks immunomodulatory effects on T cells. Clin Exp Rheumatol. 2002;20(3):379-85

Ruilope LM, Coca A, Banegas JR, Pablos JL, Luque M. Cyclo-oxygenase-2-specific inhibitors and cardiovascular morbidity. Curr Hypertens Rep. 2002;4(4):261-4

Santiago B, Galindo M, Rivero M, Brehmer MT, Mateo I, Pablos JL. The chemoattraction of lymphocytes by rheumatoid arthritis – synovial fluid is not dependent on the chemokine receptor CCR5. Rheumatol Int. 2002;22(3):107-11

.

2003

Artículos

Carreira PE. Seminarios de la Fundación Española de Reumatología: Editorial. Sem Fund Esp Reumatol. 2003;4(1):1-4

Pablos JL, Santiago B, Galindo M, Torres C, Brehmer MT, Blanco FJ, et al. Synoviocyte-derived CXCL12 is displayed on endothelium and induces angiogenesis in rheumatoid arthritis. J Immunol. 2003;170(4):2147-52

Pablos Álvarez JL. AINE liberadores de óxido nítrico. Semin Fund Esp Reumatol. 2003;4(2):57-61

.

2004

Artículos

Carreira PE. Pulmonary hypertension in autoimmune rheumatic diseases. Autoimmun Rev. 2004;3(4):313-20.

Carreira PE, Dahm MW, Norris JS. Transcription activity in fibroblasts from the adult tight skin (TSK) mouse. Clin Exp Rheumatol. 2004;22(3 Suppl 33):S77-80.

Palao G, Santiago B, Galindo M, Payá M, Ramírez JC, Pablos JL. Down-regulation of FLIP sensitizes rheumatoid synovial fibroblasts to Fas-mediated apoptosis. Arthritis Rheum. 2004;50(9):2803-10.

Pablos JL, Everett ET, Norris JS. The tight skin mouse: an animal model of systemic sclerosis. Clin Exp Rheumatol. 2004;22(3 Suppl 33):S81-5.

Santiago B, Galindo M, Palao G, Pablos JL. Intracellular regulation of Fas-induced apoptosis in human fibroblasts by extracellular factors and cycloheximide. J Immunol. 2004;172(1):560-6.

.

2005

Artículos

Carreira PE, González Crespo MR, Ciruelo E, Pablos JL, Santiago B, Gómez Camara A, et al. Polymorphism of the interleukin-1 receptor antagonist gene: a factor in susceptibility to rheumatoid arthritis in a Spanish population. Arthritis Rheum. 2005;52(10):3015-9.

Galindo M, Mateo I, Pablos JL. Multiple avascular necrosis of bone and polyarticular septic arthritis in patients with systemic lupus erythematosus. Rheumatol Int. 2005;25(1):72-6.

Galindo M, Santiago B, Palao G, Gutiérrez Cañas I, Ramírez JC, Pablos JL. Coexpression of AT1 and AT2 receptors by human fibroblasts is associated with resistance to angiotensin II. Peptides. 2005;26(9):1647-53.

Galindo M, Cabello A, Joven B, Alonso A, Carreira P, Porta J, et al. Mycophenolate mofetil induced myopathy in a patient with lupus nephritis. J Rheumatol. 2005;32(1):188-90

Jódar Gimeno E, Padrino Martínez JM, Martínez Díaz-Guerra G, Azriel Mira S, Morillas López L, Hawkins Carranza F. Densidad mineral ósea local (tibial) y axial en mujeres menopáusicas con artrosis leve a moderada. Rev Esp Enferm Metab Oseas. 2005;14(1):1-4

Joven B, González N, Aguilar F, Santiago B, Galindo M, Alcamí J, et al. Association between stromal cell-derived factor 1 chemokine gene variant and radiographic progression of rheumatoid arthritis. Arthritis Rheum. 2005;52(1):354-6.

Pablos JL, Santiago B, Tsay D, Singer MS, Palao G, Galindo M, et al. A HEV-restricted sulfotransferase is expressed in rheumatoid arthritis synovium and is induced by lymphotoxin-alpha/beta and TNF-alpha in cultured endothelial cells. BMC Immunol. 2005;6:6.

.

2006

Artículos

Gutiérrez Cañas I, Juarranz Y, Santiago B, Arranz A, Martínez C, Galindo M, et al. VIP down-regulates TLR4 expression and TLR4-mediated chemokine production in human rheumatoid synovial fibroblasts. Rheumatology (Oxford). 2006;45(5):527-32

Pablos Álvarez JL.-Las células B en la artritis reumatoide. Alteraciones sistémicas. Reumatol Clin Supl. 2006;1(1):3-7

Pablos Álvarez JL. Nuevas dianas terapéuticas en artritis reumatoide. Reumatol Clin. 2006;2(Supl 2):S9-12

Palao G, Santiago B, Galindo MA, Rullas JN, Alcamí J, Ramirez JC, et al. Fas activation of a proinflammatory program in rheumatoid synoviocytes and its regulation by FLIP and caspase 8 signaling. Arthritis Rheum. 2006;54(5):1473-81.

Paya M, Segovia JC, Santiago B, Galindo M, Del Río P, Pablos JL, et al. Optimising stable retroviral transduction of primary human synovial fibroblasts. J Virol Methods. 2006;137(1):95-102.

Santiago B, Baleux F, Palao G, Gutiérrez Cañas I, Ramírez JC, Arenzana Seisdedos F, et al. CXCL12 is displayed by rheumatoid endothelial cells through its basic amino-terminal motif on heparan sulfate proteoglycans. Arthritis Res Ther. 2006;8(2):R43.

Torres C, Belmonte R, Carmona L, Gómez Reino FJ, Galindo M, Ramos B, et al. Survival, mortality and causes of death in inflammatory myopathies. Autoimmunity. 2006;39(3):205-15.

.

2007

Artículos

Cañete JD, Santiago B, Cantaert T, Sanmartí R, Palacin A, Celis R, et al. Ectopic lymphoid neogenesis in psoriatic arthritis. Ann Rheum Dis. 2007;66(6):720-6

Collantes E, Sueiro JLF, García Vicuña R, Gratacós J. Update of the consensus of the Spanish Society of Rheumatology on the use of TNFα antagonists in spondyloarthritis, includingpsoriaticarthritis. Reumatol Clin. 2007;3(Extra 2):60-70

De la Mata Llord J, Crespo .G, Manzano JM.-Tratamiento de la artritis reumatoide con anakinra: Revisión sistemática. Reumatol Clin. 2007;3(4):153-8

Descalzo MA, Montero D, Erra A, Marsal S, Fernández Castro M, Mulero J, et al. -Registro Español de Acontecimientos Adversos de Terapias Biológicas en Enfermedades Reumáticas (BIOBADASER): Informe de la situación, 26 de enero de 2006. Reumatol Clin. 2007;3(1):4-20

.

2008

Artículos

Fernández Ruiz M, Muñoz Codoceo C, López Medrano F, Faré García R, Carbonell Porras A, Garfia Castillo C, et al. Cytomegalovirus myopericarditis and hepatitis in an immunocompetent adult: successful treatment with oral valganciclovir. Intern Med. 2008;47(22):1963-6.

Joven BE, Carreira PE. Síndrome de Raynaud: Etiología y manejo. Reumatol Clin. 2008;4(2):59-66

Pablos JL. ¿Qué es la respuesta inadecuada a anti-TNF desde el punto de vista fisiopatológico? Reumatol Clin Supl. 2008;3(1):17-23

Pérez-Zafrilla B, Descalzo M.Á, Carmona L, Sellas A, Rodríguez B, Barceló M, et al. Reacciones adversas relacionadas con la administración de inhibidores del TNF. Análisis de un registro de terapias biológicas. Reumatol Clin. 2008;4(3):90-5

.

2009

Artículos

Del Rey MJ, Izquierdo E, Caja S, Usategui A, Santiago B, Galindo M, et al. Human inflammatory synovial fibroblasts induce enhanced myeloid cell recruitment and angiogenesis through a hypoxia-inducible transcription factor 1alpha/vascular endothelial growth factor-mediated pathway in immunodeficient mice. Arthritis Rheum. 2009;60(10):2926-34

Denton CP, Engelhart M, Tvede N, Wilson H, Khan K, Shiwen X, et al. An open-label pilot study of infliximab therapy in diffuse cutaneous systemic sclerosis. Ann Rheum Dis. 2009;68(9):1433-9

Diéguez González R, Akar S, Calaza M, González Álvaro I, Fernández-Gutiérrez B, Lamas JR, et al. Lack of association with rheumatoid arthritis of selected polymorphisms in 4 candidate genes: CFH, CD209, Eotaxin-3, and MHC2TA. J Rheumatol. 2009;36(8)1590-5

Galindo M, Gonzalo E, Martínez Vidal MP, Montes S, Redondo N, Santiago B, et al. Immunohistochemical detection of intravascular platelet microthrombi in patients with lupus nephritis and anti-phospholipid antibodies. Rheumatology (Oxford). 2009;48(8):1003-7

Izquierdo E, Cañete JD, Celis R, Santiago B, Usategui A, Sanmartí R, et al. Immature blood vessels in rheumatoid synovium are selectively depleted in response to anti-TNF therapy. PLoS ONE. 2009;4(12):e8131

Movasat A, Shahram F, Carreira PE, Nadji A, Akhlaghi M, Naderi N, et al. Nailfold capillaroscopy in Behçet’s disease, analysis of 128 patients. Clin Rheumatol. 2009;28(5):603-5

Pablos Álvarez JL. La interleucina 6 en la fisiopatología de la artritis reumatoide. Reumatol Clin. 2009;5(1):34-9

Peña Sagredo JL, Fariñas MC, Pérez Zafrilla B, Cruz Valenciano A, Crespo M, Joven Ibañez B, et al.; BIOBADASER and EMECAR Groups. Non-typhi Salmonella infection in patients with rheumatic diseases on TNF-alpha antagonist therapy. Clin Exp Rheumatol. 2009;27(6):920-5

Ruiz Cano MJ, Escribano P, Alonso R, Delgado J, Carreira P, Velázquez T, et al. Comparison of baseline characteristics and survival between patients with idiopathic and connective tissue disease-related pulmonary arterial hypertension. J Heart Lung Transplant. 2009;28(6):621-7

Suárez Gestal M, Calaza M, Diéguez González R, Pérez-Pampin E, Pablos JL, Navarro F, et al. Rheumatoid arthritis does not share most of the newly identified systemic lupus erythematosus genetic factors. Arthritis Rheum. 2009;60(9):2558-64

.

2010

Artículos

Beretta L, Santaniello A, Cappiello F, Chawla N, Vonk M, Carreira P, et al. Development of a five-year mortality model in systemic sclerosis patients by different analytical approaches. Clin Exp Rheumatol. 2010;28(Suppl 58):18-27

Joven BE, Almodóvar R, Carmona L, Carreira PE. Survival, causes of death, and risk factors associated with mortality in Spanish systemic sclerosis patients: results from a single university hospital. Semin Arthritis Rheum. 2010;39(4):285-93

Pablos Álvarez JL. Bases patogénicas de la terapia dirigida a las células B en el lupus eritematoso sistémico (LES). Reumatol Clin. 2010;6(Suppl 2):21-4